论文部分内容阅读
Bis(propyl)-cognitin (B3C),derived from tacrine linking with three methylene (-CH2-) groups,is a multi-target dimmer.During the past several years,it has been reported as a promising therapeutic drug for Alzheimers disease (AD) and other neurodegenerative disorders.However,the therapeutic mechanism of B3C for AD needs further demonstration.